Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B‐cell non‐Hodgkin lymphoma: 7‐year follow‐up results
暂无分享,去创建一个
Y. Ohashi | M. Ogura | T. Kinoshita | K. Tobinai | K. Itoh | Y. Morishima | Takashi Watanabe | T. Igarashi | T. Hotta | T. Terauchi